- KATHLEEN MAHER
- Nada Rashid
- Megan Ringo
Substance use disorders are effectively addressed in general health care settings. However, the practice is not as widespread as would be optimal for addressing the individual and population health impacts of risky and problem substance use. ECHO seeks to enhance this service provision through shared learning and expert consultation across members of the healthcare team in a diverse, inclusive, and equitable manner. An example of suboptimal care is shown in the case information provided as a resource.
MD/DO, RN, APRN, Physician Assistants, Pharmacists, Pharmacy Technicians, Psychologists, Social Workers, Patients/Caregivers, and Students.
|Randy Brown, MD PhD, Chair||Nada Rashid, Coordinator||Kathleen Maher, Coordinator|
|Ritu Bhatnagar, DO||Susan Mindock, LPC, CSAC||Sheila Weix, MSN, RN, CARN|
|Kellene Eagen, MD||Joesph Galey, CPS||Paul Hutson, PharmD|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1 hour of knowledge-based CE credit. Credit can be earned by successfully completing this live activity. Pharmacists and Pharmacy Technicians should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion.
2022 Universal Activity Number (UAN): JA0000358-0000-22-098-L01-P; JA0000358-0000-22-098-L01-T
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Patient Care and Procedural Skills
Practice-Based Learning and Improvement
Interpersonal and Communication Skills
Provide Patient/Person-Centered Care
Employ Evidence-Based Practice
Apply Quality Improvement
INTERPROFESSIONAL EDUCATION COLLABORATIVE COMPETENCIES
Values/Ethics for Interprofessional Practice
Teams and Teamwork
DIVERSITY, EQUITY, AND INCLUSION COMPETENCIES
Engage in Self-Reflection
Address Health Disparities
Value Diversity in the Clinical Encounter
ADDITIONAL ACTIVITY GOALS
|JAC 18||JAC 19||JAC 20||JAC 23|
IP — COMPETENCE/PERFORMANCE
As a result of participation in this educational series, clinical teams will:
- Implement appropriate opioid prescribing and monitoring practices in an ethical fashion
- Effectively participate and communicate in office-based, collaborative management of substance use disorders
- Consistently provide overdose prevention education to appropriate patients while keeping diversity, equity, and inclusion concepts in mind
- Identify the role of medication assisted therapies, such as methadone, naltrexone, and buprenorphine, and contributions of different members of the healthcare team to the management of substance use disorders